EU Parliament Pharma Intergroup

28 April 1996

Members of the European Parliament have formed a Pharmaceutical Intergroup, which held its first meeting in the third week of April in Strasbourg, it was reported at the third Annual Conference of European Medicines Agencies last week (see page 13). Intergroups consist of members of different parliamentary committees, meeting to discuss matters of mutual interest.

The meeting was opened by Sir James Black, and its topic was the protection and promotion of pharmaceutical innovation. Further meetings will be held shortly, one of which will focus on orphan drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight